Stem cell therapy approved for clinical trials
PALO ALTO, Calif. (KGO) -- A therapy developed by Palo Alto-based Stem Cells Inc. and researchers at U.C. Irvine has been approved for the world's first clinical trial using human neural stem cells to treat spinal cord injuries.
The treatment will target spinal injuries that are three to 12 months old.
Researchers will begin enrolling patients early next year.
stem cell research, palo alto, health
- Family: Children's Hospital calls girl 'dead'
- BART Board president wants to ban transit strikes
- Dozens hurt after London theater partially collapsed
- 'Duck Dynasty' fans react to Robertson's hiatus
- 'Wonder Girl' cancer patient is inspiration for Vallejo
- Report says bullying of American-Islamic kids on rise
- 1 dead, dozens hurt in California bus crashes
- Seismic saddles in place on new Bay Bridge 35 min ago
- Only On 7: Sneak peek at the SF Zoo's baby gorilla
- 7 On Your Side looks into Lyft's donation policy
- abcnews: Dennis Rodman does karaoke in NKorea
- Bay Area New Year's Eve fireworks and events
- roundup: Toy drive in need; Timeshare sales scam
- weather: Bay Area weather forecast for Friday
- Last minute Christmas shopping is in full...
23 min ago
Most Viewed StoriesMost Viewed Photos